RELB Antikörper (N-Term)
Kurzübersicht für RELB Antikörper (N-Term) (ABIN925884)
Target
Alle RELB Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Kreuzreaktivität
- Ratte (Rattus), Human
-
Immunogen
- RELB antibody was raised in rabbit using the N terminal of RELB as the immunogen
-
-
-
-
Applikationshinweise
-
WB: 2.5 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
RELB Blocking Peptide, (ABIN5615829), is also available for use as a blocking control in assays to test for specificity of this RELB antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 100 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- RELB (V-Rel Reticuloendotheliosis Viral Oncogene Homolog B (RELB))
-
Andere Bezeichnung
- RELB
-
Hintergrund
- RelB is a member of the Rel/nuclear factor (NF)-kappa B family of transcription factors, defects in RelB affects antigen presenting cells and the formation of lymphoid organs. Targeted disruption of the Rel/NF-kappaB family members NF-kappaB2, encoding p100/p52, and RelB in mice results in anatomical defects of secondary lymphoid tissues. Synonyms: Polyclonal RELB antibody, Anti-RELB antibody.
-
Pathways
- NF-kappaB Signalweg, RTK Signalweg
Target
-